Platelet-rich plasma is a useful therapeutic option in melasma
- 29 November 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 30 (4) , 396-401
Abstract
Background: Melasma is a cosmetically disfiguring disorder of facial pigmentation. Objectives: We evaluated the value of platelet-rich plasma (PRP) in the treatment of melasma using two different delivery techniques: microneedling using dermapen versus microinjections using mesoneedles. Patients and methods: Twenty-three adult Egyptian melasma patients were enrolled. Wood's light was used to determine the histological type of melasma. Autologous PRP was delivered into the lesional melasma skins through microneedling with dermapen on the right side of the face and intradermal microinjections using mesoneedles on the left side of the face (for each patient). The treatment was done regularly (three sessions, each month). The response to PRP therapy was measured using melasma area and severity index (MASI) and modified melasma area and severity index (mMASI) that were calculated before and after three treatment sessions. Hemi-MASI was used to compare the effectiveness of the two delivery techniques. Results: Following PRP treatment, MASI and mMASI scores decreased significantly from 11.86 ± 5.25 to 6.96 ± 4.82, and from 5.71 ± 2.56 to 2.90 ± 2.05, respectively (p < .000,). A statistically significant decrease was noted in the hemi-MASI score on each side of the face following PRP treatment (p < .000), but there was no significant difference in comparing both sides. Conclusions: Our study provides the first indication about the value of PRP as a useful and new therapeutic option in melasma. Moreover, our study was the first to compare PRP delivery through microneedling versus microinjections.Keywords
Funding Information
- Quality assurance Unit at Faculty of Medicine, Assiut University (15509)
This publication has 20 references indexed in Scilit:
- Epidermal Growth Factor and Epidermal Growth Factor Signaling Attenuate Laser-Induced MelanogenesisDermatologic Surgery, 2013
- Plasma rico en plaquetas: ¿un nuevo tratamiento para el reumatólogo?Reumatología Clínica, 2013
- A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasmaJournal of Cutaneous and Aesthetic Surgery, 2013
- Melasma pathogenesis and influencing factors – an overview of the latest researchJournal of the European Academy of Dermatology and Venereology, 2012
- Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring methodJournal of the American Academy of Dermatology, 2011
- Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal FibroblastAnnals of Dermatology, 2011
- Effect of melasma on quality of life in a sample of women living in southern BrazilJournal of the European Academy of Dermatology and Venereology, 2008
- An Analysis of a Rapid, Simple, and Inexpensive Technique Used to Obtain Platelet-Rich Plasma for Use in Clinical PracticeJournal of Oral Implantology, 2008
- Topical Retinoic Acid (Tretinoin) for Melasma in Black PatientsArchives of Dermatology, 1994
- Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence studyJournal of the American Academy of Dermatology, 1981